A team led by Professor Takaaki Abe at the Tohoku University Graduate School of Medicine has uncovered an unexpected approach by repurposing a constipation medication. Their work marks the first time that this drug (lubiprostone) has been shown to slow the loss of kidney function in people with CKD.
Related Posts
Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?
Post Views: 29 The rational use of medicines and diagnostics…
Every other agri worker with chronic kidney disease has it due to unknown cause, study finds
Post Views: 6 Researchers, including those from Madras Medical College,…
Regulator finds toxic contaminant in cough syrup linked with deaths in MP
Post Views: 25 While the Union Health Ministry had earlier…